COVID 19 Monoclonal Antibody IV Therapy

We are excited to now offer COVID 19 Monoclonal Antibody IV Therapy to patients with mild to moderate COVID-19 symptoms and exposure.

Monoclonal Antibody IV Therapy is a promising treatment for non-hospitalized patients who are at high risk of complications from COVID-19 or who have mild to moderate symptoms associated with the COVID-19 virus.

Monoclonal antibodies are lab-produced proteins designed to mimic your body’s antibodies that are used to fight off infection and viruses. These specific antibodies are designed to bind to part of the COVID-19 virus protein and prevent the further spread of infection of exposure.

The goal of treatment is to prevent hospitalizations and reduce symptom severity.

It is important to note that treatment can only be used after infection or exposure and is not a substitute for a COVID-19 vaccine.

Monoclonal Antibody IV Therapy is appropriate for patients at high risk of developing severe symptoms, patients with mild to moderate symptoms, or patients with known exposure to the COVID-19 virus. It can be given to anyone over the age of 12.

People eligible may also include those who:

  • Are at a higher risk of exposure

  • Have certain medication conditions that have compromised the immune system

  • May not be fully protected by a COVID-19 vaccine due to medical health complications

Monoclonal Antibody IV Therapy is given through intravenous (IV) infusion. The antibody infusion takes about 20 minutes and is often followed by an hour of observation and monitoring for allergic reactions. Patients should expect the entire process to take about 2-3 hours.

Side effects associated with monoclonal antibodies may include fever, nausea, difficulty breathing, fatigue, weakness, headache, muscle aches, low blood pressure, and confusion.

Patients may notice soreness, swelling, and slight discomfort from the IV infusion.

In November of 2020, the Federal Drug Administration gave emergency authorization to the use of Monoclonal Antibody IV Therapy for non-hospitalized COVID-19 patients.

If you have tested positive for COVID-19 or believe you’ve recently become exposed, Monoclonal Antibody IV Therapy may be right for you in preventing symptom severity and reducing the risk of hospitalization. For more information on Monoclonal Antibody IV Therapy for COVID-19 and our services or to schedule an appointment, contact our office today.